Walgreens Boots Alliance
Financial Performance
Walgreens Boots Alliance Revenue & Financials
Revenue
$147.7B (FY2024)
Employees
211,000
What is Walgreens Boots Alliance's revenue?
Walgreens Boots Alliance had $147.7B in revenue for fiscal year 2024, up 6.2% from 2023. It reported a net loss of $8.6B.
- Latest revenue
- $147.7B (FY2024)
- Year-over-year
- +6.2%
- Growth rate (CAGR)
- 4% over 9 years
- Peak revenue
- $147.7B (FY2024)
- Years of data
- 10
- Employees
- 211,000
- How much profit does Walgreens Boots Alliance make?
- Walgreens Boots Alliance reported a net loss of $8.6B for fiscal year 2024. sec.gov
- How many employees does Walgreens Boots Alliance have?
- Walgreens Boots Alliance has about 211,000 employees.
Financial Analysis
WBA's sales grew from $103.4 billion in FY2015 to $147.7 billion in FY2024, but profits fell away. FY2023 ended with a $3.1 billion net loss and FY2024 with an $8.6 billion loss, driven largely by impairments tied to VillageMD and U.S. Healthcare along with opioid-related charges. WBA did not file a full FY2025 annual report because the Sycamore deal closed on August 28, 2025, days before the August 31 fiscal year-end. As a private company, Walgreens no longer publishes quarterly results.
Revenue Trend Analysis
YoY Change
+6.2%
9-Year CAGR
+4%
Peak Year
2024
Trend
Consistent Growth
Walgreens Boots Alliance has 10 full fiscal year figures on this page, compounding at +4% annually over 9 years. The most recent year saw a 6.2% increase versus the prior year. Annual revenue peaked in fiscal year 2024 at $147.7B. Of 9 comparable year-over-year steps, 8 showed growth and 1 showed a decline.
Annual revenue history
Click any row to see year details.
Keep researching Walgreens Boots Alliance
Walgreens Boots Alliance Revenue and Financial FAQ
What were Walgreens Boots Alliance's final audited public revenues in FY2024?
In fiscal year 2024 (ended August 31, 2024), WBA reported net sales of $147.7 billion, up 6.2% year-over-year, driven by US pharmacy prescription volume growth and drug inflation.
Why did WBA report a massive net loss of $8.6 billion in FY2024?
The net loss was driven by $12.4 billion in non-cash pre-tax charges, primarily a $5.8 billion goodwill impairment on VillageMD, a $2.7 billion impairment on long-lived store assets, and ongoing opioid settlement reserves.
What was the transaction value of the August 2025 Sycamore Partners buyout?
Sycamore Partners completed the take-private acquisition of Walgreens Boots Alliance in an all-cash transaction valuing the enterprise at approximately $10 billion to $12 billion plus assumed liabilities.
Why was Walgreens Boots Alliance removed from the Dow Jones Industrial Average (DJIA)?
In February 2024, S&P Dow Jones Indices removed WBA from the prestigious 30-stock Dow Jones Industrial Average (replacing it with Amazon.com) following prolonged stock underperformance.
What was Walgreens' dividend track record prior to the buyout?
Walgreens had been a Dividend Aristocrat with 47 consecutive years of dividend increases until January 2024, when the board slashed the quarterly dividend by 48% (from $0.48 to $0.25 per share) to preserve cash.
How did WBA monetize its equity holdings in Cencora (AmerisourceBergen)?
Between 2021 and 2024, WBA executed multiple secondary share sales and forward transactions of its Cencora stock, raising over $4.5 billion in cash to pay down outstanding term debt.
What is the private capital structure of Walgreens under Sycamore Partners?
As a private company, Walgreens operates with a bespoke private equity capital structure funded by Sycamore's equity commitment alongside restructured asset-backed lending (ABL) and term debt facilities.
How much operating cash flow does Walgreens generate from core retail pharmacy?
Historically, the core US retail pharmacy operation generated $1.5 billion to $2.5 billion in annual operating cash flow before healthcare venture impairments and opioid settlement payouts.
How did store-level comparable sales perform in 2024 and 2025?
Comparable pharmacy sales grew 4% to 6% due to brand-name prescription inflation and GLP-1 weight-loss drug demand, while front-of-store retail comps declined 1% to 3% due to cautious consumer spending.
What are the cost-savings targets of the private operating turnaround?
Sycamore Partners and CEO Mike Motz launched programs targeting $1.0 billion in run-rate overhead cost reductions by closing underperforming stores, consolidating distribution hubs, and reducing corporate headcount.
How do long-term lease liabilities affect Walgreens' financial flexibility?
Walgreens carries billions in operating lease obligations; under private ownership, restructuring professionals negotiate lease restructurings, rent concessions, and orderly terminations with commercial landlords.
Does private Walgreens disclose quarterly financial statements?
No; following the completion of the take-private merger on August 28, 2025, and deregistration with the SEC, Walgreens ceased public quarterly Form 10-Q and annual 10-K financial reporting.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Walgreens Boots Alliance Revenue & Financials." CorpDigest, https://corpdigest.com/company/walgreens-boots-alliance/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Walgreens Boots Alliance reported $147.7B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/walgreens-boots-alliance/financials" target="_blank" rel="noopener">CorpDigest — Walgreens Boots Alliance financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore Walgreens Boots Alliance
Core profile pages, founders and related research hubs for this company.